Trial of lurbinectedin for small cell lung cancer meets primary endpoint - Healio

Trial of lurbinectedin for small cell lung cancer meets primary endpoint  Healio

A phase 2 trial designed to evaluate the safety and efficacy of lurbinectedin for patients with relapsed small cell lung cancer met its primary endpoint of overall ...



Comments

Popular posts from this blog

A Review of the Etiology and Epidemiology of Bladder Cancer: All ...

Oncology: The disease, dynamics & challenges of market research

Respirology | APSR Respiratory Medicine Journal